Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114807) titled 'Development of a Standardized Culture Platform for Hepatopancreatobiliary Tumor Organoids and Exploration of Its Clinical Translational Potential' on Dec. 17, 2025.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: Chongqing General Hospital
Condition:
hepatocellular carcinoma, cholangiocarcinoma, and pancreatic cancer
Intervention:
pancreatic cancer:Surgery
cholangiocarcinoma:Surgery
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-06-16
Target Sample Size: pancreatic cancer:33;cholangiocarcinoma:33;hepatocellular carcinoma:34;
Countries of Recruitm...